TScan Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of TCRX for the last quarter is 1.05 M USD, and it's 95.71% higher compared to the previous quarter. The net income of Q3 24 is -29.89 M USD.